RISK FACTORS FOR CLINICALLY SIGNIFICANT UPPER AND LOWER GASTROINTESTINAL EVENTS: THE CONDOR TRIAL

(1) University of Zaragoza, CIBERehd, Medicine-Gastroenterology, Zaragoza, Spain

(2) University of Michigan, AnnArbor, United States

(3) University of Illinois atChicago, Chicago, United States

(4) The Chinese University ofHong Kong, Hong Kong, China

(5) University of Virginia, Charlottesville, United States

(6) Pfizer Inc., New York, UnitedStates



This item was part of the GI bleeding: Risk factors and natural history session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A61